PNPLA3 was also associated with prevalence, pathological severity—including that of liver fibrosis—hepatocarcinogenesis, and mortality in NAFLD patients [21,36,37]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.